Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan. Issue 12 (December 1979)

• Record Type: Journal Article
• Authors: Baumgartner, G; Gawel, M J; Kaeser, H E; Pallis, C A; Rose, F C; Schaumburg, H H; Thomas, P K; Wadia, N H
• Is Part Of: Journal of neurology, neurosurgery and psychiatry. Volume 42:Issue 12(1979)
• Page Start: 1073
• Page End: 1083
• Publication Date: 1979-12
• Subjects: Neurology -- Periodicals; Nervous system -- Surgery -- Periodicals; Psychiatry -- Periodicals; 616.8
• DOI: 10.1136/jnnp.42.12.1073
• Languages: English
• ISSNs: 0022-3050

Abstract

Abstract : An analysis is presented of 220 cases of possible neurotoxic reactions to halogenated hydroxyquinolines reported from outside Japan. In 80 cases insufficient information was available for adequate comment and in 29 a relationship to the administration of clioquinol could be excluded. Of the remainder, a relationship to clioquinol was considered probable in 42 and possible in 69 cases. In six of the probable cases the neurological disturbance consisted of an acute reversible encephalopathy usually related to the ingestion of a high dose of clioquinol over a short period. The most common manifestation, observed in 15 further cases, was isolated optic atrophy. This was most frequently found in children, many of whom had received clioquinol as treatment for acrodermatitis enteropathica. In the remaining cases, a combination of myelopathy, visual disturbance, and peripheral neuropathy was the most common manifestation. Isolated myelopathy or peripheral neuropathy, or these manifestations occurring together, were infrequent. The onset of all manifestations (except toxic encephalopathy) was usually subacute, with subsequent partial recovery. Older subjects tended to display more side effects. The full syndrome of subacute myelo-optic neuropathy was more frequent in women, but they tended to have taken greater quantities of the drug.